Selected article for: "maximum likelihood method and phylogenetic analysis"
Title: Research Communications of the 27(th) ECVIM-CA Congress: Intercontinental, Saint Julian's, Malta, 14th to 16th September 2017
  • Document date: 2017_11_7
    • ID: roslkxeq_363
    Snippet: Disclosures: No disclosures to report. The aim of this study was to i) determine whether there is evidence of CPPV1 infection in feral carnivores and viral traffic between these and companion animals (ii) model in silico the susceptibility of the Tasmanian devil to CPPV1. Reticuloendothelial tissue samples were sourced from deceased feral carnivores for PCR amplification and sequencing of a 529 bp region of the CPPV1 VP2 gene. Phylogenetic analys.....
    Document: Disclosures: No disclosures to report. The aim of this study was to i) determine whether there is evidence of CPPV1 infection in feral carnivores and viral traffic between these and companion animals (ii) model in silico the susceptibility of the Tasmanian devil to CPPV1. Reticuloendothelial tissue samples were sourced from deceased feral carnivores for PCR amplification and sequencing of a 529 bp region of the CPPV1 VP2 gene. Phylogenetic analysis of partial VP2 gene sequences was performed using the maximum likelihood method. Tasmanian devil susceptibility to infection was investigated by comparison of their transferrin receptor type 2 (TfR) sequence at binding sites for CPPV1 to susceptible carnivores, and phylogenetic analysis of TfR protein.

    Search related documents:
    Co phrase search for related documents
    • bp region and gene sequence: 1, 2, 3, 4, 5, 6
    • bp region and likelihood method: 1
    • bp region and maximum likelihood method: 1
    • bp region and PCR amplification: 1, 2, 3
    • bp region and phylogenetic analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • bp region and study aim: 1
    • gene sequence and likelihood method: 1, 2
    • gene sequence and maximum likelihood method: 1, 2
    • gene sequence and partial VP2 gene sequence: 1
    • gene sequence and PCR amplification: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • gene sequence and phylogenetic analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • gene sequence and sequencing PCR amplification: 1, 2, 3, 4, 5
    • gene sequence and study aim: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • likelihood method and maximum likelihood method: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • likelihood method and PCR amplification: 1, 2
    • likelihood method and phylogenetic analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • likelihood method and study aim: 1, 2, 3, 4, 5, 6, 7
    • maximum likelihood method and PCR amplification: 1, 2
    • maximum likelihood method and study aim: 1, 2, 3, 4, 5